Daily as of 3 Nov 16:00 ET
- Price
- above both $99.55 vs 50 $88.17 / 200 $69.88
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 29 Aug 2025 · projected 19 bars out
ORKA | Oruka TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$99.55
+$4.12 (+4.32%)
Oruka Therapeutics (ORKA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- above both $99.55 vs 50 $83.99 / 200 $90.05
- Projection
- 🟨Golden cross estimated in 16 to 22 bars
- Test
- No active test
- Last cross
- 💀Death cross 14 Oct 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Oct 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 29 Aug 2025 | 🟨Golden moderate | daily | 19 bars out | Not tested |
About ORKA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$76.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandmid